Fight against cancer: Partners for a vaccine
Jul 13, 2010
Firm joins cancer fight
Jul 13, 2010
Immunovaccine Delivers A Shot In The Arm
Jun 30, 2010
Bioscience firm finds Israeli partner
Jun 08, 2010
Coaxing cancer to defect
May 27, 2010
The Shifting Landscape Toward Immunotherapies
May 17, 2010
Medical trials push firm's costs
May 13, 2010
Companies to watch: Immunovaccine
May 11, 2010
Warwick Kimmins Science Scholarship 2010
Apr 21, 2010
Immunovaccine full-year loss cut to $1.7M from $3.7M; changes fiscal year end
Apr 19, 2010
Immunovaccine secures CRO Cato Research for imminent Phase I cancer vaccine trial – CEO
Mar 19, 2010
End goal: to make a difference for mankind
Mar 06, 2010
Immunovaccine IPO Top Life Sciences Story
Mar 04, 2010
Paradigm starts Immunovaccine at buy
Mar 01, 2010
DepoVax could mean fewer doses of anthrax vaccine needed
Feb 10, 2010
Life sciences community thriving
Feb 08, 2010
Cancer vaccine set for clinical trials, being pitched to investors
Feb 05, 2010
Dr. Randal Chase speaks at Biotech Showcase
Feb 02, 2010
Capital gains
Jan 13, 2010
Bridging the divide
Jan 11, 2010
Cancer vaccine clears another hurdle
Dec 10, 2009
Biotech firm inks Pfizer deal
Nov 24, 2009
Pfizer, Immunovaccine in animal vaccine deal
Nov 23, 2009
Halifax firm working on cancer vaccine
Nov 11, 2009
Immunovaccine works with Cato Research in cancer vaccine trial
Nov 10, 2009
Deal reached to help manage clinical trial
Nov 03, 2009
A better vaccine for anthrax
Oct 30, 2009
ON THE MOVE
Sep 29, 2009
Biotech firm goes public
Sep 26, 2009
Bioscience company gets $260,000 grant
Jul 29, 2009
ON THE MOVE
Jul 14, 2009
ImmunoVaccine Signs Licenses Agreement With Immunotope
Jul 14, 2009
Local cancer biotech firm to go public
Jun 12, 2009
ImmunoVaccine Technologies and FIT Biotech enter partnership on DNA-based vaccine
May 25, 2009
Swine Flu Situation Highlights Crucial Need for Sustained Dialogue on Vaccines in Canada
Apr 30, 2009
Vaccine development firm signs 3-year deal with military agency to conduct vaccine research
Apr 15, 2009
IVT Delays Acquisition, Seeks Smaller Round
Mar 30, 2009
La Jolla Institute to Test IVT’s Delivery Platform with Infectious Disease Candidates
Mar 27, 2009
ImmunoVaccine Technologies calls for 2009 applicants for the Warwick Kimmins Science Scholarship
Mar 16, 2009
BioPartnering North America Almost Over
Feb 10, 2009
Vaccine Development Aided by New Techniques
Nov 01, 2008
IVT patents DepoVax vaccine delivery system
May 12, 2008
Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
Apr 29, 2008
Funding boost for innovative VacciMax platform
Jan 22, 2008
IVT receives 2006 NRC-IRAP Regional Awards for New Technology
Jan 12, 2007
IVT receives Innovation Award at Discovery Awards banquet
Jan 12, 2007
IVT announces addition of Dr. Randal Chase as President & CEO
Dec 01, 2006
IVT announces addition of Mr. Ron Smith as Chief Financial Officer
Sep 13, 2006
IVT Therapeutic Cancer Vaccine Workshop being held October 19th & 20th, 2006
Aug 31, 2006
Dr. Michel Klein, IVT Scientific Advisor, receives prestigious award.
Mar 03, 2006
IVT announces addition of Mr. Ron Smith and Mr. Wade Dawe to the Board of Directors.
Dec 09, 2005
IVT announces addition of Dr. Michel Klein to the Scientific Advisory Board.
Aug 04, 2005
ImmunoVaccine Technologies Earns National Recognition
May 30, 2005
Dr. Marc Mansour, Head Scientist, Reproductive Biology and Head Scientist, Infectious Diseases
Mar 24, 2004